Literature DB >> 19782584

Facilitated cardiac recovery in fulminant myocarditis: pediatric use of the Impella LP 5.0 pump.

Jason G Andrade1, Hesham Al-Saloos, Aamir Jeewa, George G S Sandor, Anson Cheung.   

Abstract

We describe the successful use of the Impella LP 5.0 intracardiac microaxial pump (Abiomed, Danvers, MA) in a 13-year-old boy with fulminant biopsy-proven viral myocarditis. The patient, who previously was in refractory cardiogenic shock despite increasing inotropic and vasopressor support, immediately stabilized after Impella LP 5.0 implantation and was successfully bridged to a full recovery. Months later, he remains completely well, with no intracardiac or peripheral vascular sequelae of the procedure. In carefully selected pediatric patients the Impella may be a beneficial form of temporary mechanical circulatory support for fulminant cardiogenic shock. Copyright (c) 2010 International Society for Heart and Lung Transplantation. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 19782584     DOI: 10.1016/j.healun.2009.06.020

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN: 1053-2498            Impact factor:   10.247


  12 in total

1.  Acute Cardiac Unloading and Recovery: Proceedings of the 4th Annual Acute Cardiac Unloading and REcovery (A-CURE) symposium held on 30 August 2019 in Paris, France.

Authors: 
Journal:  Interv Cardiol       Date:  2019-11-18

2.  A multicenter study of the impella device for mechanical support of the systemic circulation in pediatric and adolescent patients.

Authors:  V Vivian Dimas; Brian H Morray; Dennis W Kim; Christopher S Almond; Shabana Shahanavaz; Sebastian C Tume; Lynn F Peng; Doff B McElhinney; Henri Justino
Journal:  Catheter Cardiovasc Interv       Date:  2017-03-15       Impact factor: 2.692

Review 3.  Current approaches to device implantation in pediatric and congenital heart disease patients.

Authors:  Jacob R Miller; Timothy S Lancaster; Pirooz Eghtesady
Journal:  Expert Rev Cardiovasc Ther       Date:  2015-03-03

Review 4.  Ventricular assist device use in congenital heart disease with a comparison to heart transplant.

Authors:  Jacob R Miller; Pirooz Eghtesady
Journal:  J Comp Eff Res       Date:  2014-09       Impact factor: 1.744

Review 5.  Pediatric ventricular assist devices.

Authors:  Iki Adachi; Sarah Burki; Farhan Zafar; David Luis Simon Morales
Journal:  J Thorac Dis       Date:  2015-12       Impact factor: 2.895

Review 6.  Mechanical circulatory support for end-stage heart failure in repaired and palliated congenital heart disease.

Authors:  Joseph B Clark; Linda B Pauliks; John L Myers; Akif Undar
Journal:  Curr Cardiol Rev       Date:  2011-05

7.  Incidence and management of life-threatening adverse events during cardiac catheterization for congenital heart disease.

Authors:  C Huie Lin; Sanjeet Hegde; Audrey C Marshall; Diego Porras; Kimberlee Gauvreau; David T Balzer; Robert H Beekman; Alejandro Torres; Julie A Vincent; John W Moore; Ralf Holzer; Laurie Armsby; Lisa Bergersen
Journal:  Pediatr Cardiol       Date:  2013-07-31       Impact factor: 1.655

8.  Augmenting Function for Infarction from Infection: Impella 2.5 for Ischemic Cardiogenic Shock Complicating Sepsis.

Authors:  Praveen George; Mukta C Srivastava; Jonathan Ludmir; Robert M Reed; Semhar Z Tewelde; Anuj Gupta; Michael T McCurdy
Journal:  Case Rep Cardiol       Date:  2017-02-05

9.  Past and present of cardiocirculatory assist devices: a comprehensive critical review.

Authors:  Gianluca Rigatelli; Francesco Santini; Giuseppe Faggian
Journal:  J Geriatr Cardiol       Date:  2012-12       Impact factor: 3.327

10.  Novel combination of impella and extra corporeal membrane oxygenation as a bridge to full recovery in fulminant myocarditis.

Authors:  Sachin Narain; Gian Paparcuri; Thomas M Fuhrman; Richard B Silverman; William T Peruzzi
Journal:  Case Rep Crit Care       Date:  2012-07-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.